Rapid Diagnostic Test Kits Market Analysis Focusing on Growth Potential and Outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Rapid Diagnostic Test Kits Market Over The 2026–2030 Period?

The rapid diagnostic test kits market size has demonstrated robust growth over recent years. It is anticipated to expand from $24.08 billion in 2025 to $25.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This historical development can be attributed to several factors including the rising incidence of infectious diseases, the wider adoption of decentralized healthcare services, an increased desire for swift diagnostic findings, the expansion of testing in outpatient settings and homes, and the widespread availability of lateral flow and immunoassay technologies.

The rapid diagnostic test kits market is anticipated to experience substantial growth over the coming years. By 2030, this market is projected to reach $32.22 billion, exhibiting a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period is primarily driven by factors such as greater investment in rapid diagnostic innovation, a surge in the adoption of self-testing kits, the widening scope of infectious disease surveillance programs, an increasing need for economical diagnostics in developing economies, and the growing incorporation of digital readout technologies. Key developments expected in the forecast period encompass a rising embrace of point-of-care testing solutions, heightened demand for multiplex rapid test kits, an increase in home-based diagnostic testing, the proliferation of portable and disposable test formats, and a sharper emphasis on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24678&type=smp

Which Primary Drivers Are Impacting The Rapid Diagnostic Test Kits Market Growth?

The rapid diagnostic test kits market is set for growth, driven by the escalating occurrence of infectious diseases. These illnesses are characterized by pathogenic microorganisms like bacteria, viruses, fungi, or parasites that can spread directly or indirectly among individuals. The rising incidence of infectious diseases is fueled by factors such as antimicrobial resistance and evolving pathogen strains, where extensive antibiotic use fosters drug-resistant bacterial infections, and viruses continually mutate to create new variants that bypass existing immunity, thereby demanding updated detection methods. This increasing prevalence of infectious diseases boosts the adoption of point-of-care testing devices, which facilitate the rapid identification of pathogens, enabling healthcare providers to promptly diagnose infections, initiate appropriate treatment, and implement timely infection control measures. As an illustration, the Centers for Disease Control and Prevention, a US-based government agency, reported in March 2024 that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the expanding prevalence of infectious diseases is a key factor propelling the rapid diagnostic test kits market.

Which Segment Types Are Examined In The Rapid Diagnostic Test Kits Market Segment Study?

The rapid diagnostic test kits market covered in this report is segmented –

1) By Product Type: Antigen Test Kits, Antibody Test Kits, Nucleic Acid Test Kits, Multi-Analyte Test Kits

2) By Technology: Fluorescent Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA), Colloidal Gold-Based Test, Lateral Flow Assays

3) By Application: Infectious Disease Testing, Cardiology Testing, Oncology Testing, Pregnancy And Fertility Testing, Toxicology Testing, Glucose Monitoring, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Home Care Settings, Pharmacies

Subsegments:

1) By Antigen Test Kits: COVID-19 Antigen Test Kits, Influenza Antigen Test Kits, Malaria Antigen Test Kits, Respiratory Syncytial Virus Antigen Test Kits, Streptococcus Antigen Test Kits

2) By Antibody Test Kits: HIV Antibody Test Kits, Hepatitis Antibody Test Kits, COVID-19 Antibody Test Kits, Dengue Antibody Test Kits, Syphilis Antibody Test Kits

3) By Nucleic Acid Test Kits: HIV Nucleic Acid Test Kits, Hepatitis B And C Nucleic Acid Test Kits, Human Papillomavirus Nucleic Acid Test Kits, Tuberculosis Nucleic Acid Test Kits, COVID-19 Nucleic Acid Test Kits

4) By Multi-Analyte Test Kits: Respiratory Panel Test Kits, Sexually Transmitted Infections Panel Test Kits, Gastrointestinal Panel Test Kits, Febrile Illness Panel Test Kits, Sepsis Marker Panel Test Kits

Which Trends Are Shaping Growth In The Rapid Diagnostic Test Kits Market?

Leading firms within the rapid diagnostic test kits market are concentrating on creating innovative solutions, like saliva-based pregnancy test kits, to achieve a competitive advantage in the industry. These saliva-based pregnancy test kits function as diagnostic instruments, engineered to identify pregnancy through the analysis of a woman’s saliva for specific hormonal shifts, especially human chorionic gonadotropin (hCG), a hormone generated during gestation. An example is the launch of Salistick in February 2023 by Abingdon Health plc, a UK-based near-patient diagnostics company. This product represents the inaugural rapid saliva-based pregnancy test available in the UK and Ireland, signifying a notable advancement in at-home pregnancy testing by providing a more hygienic and user-friendly option compared to conventional urine-based methods. This highly accurate test identifies the pregnancy hormone ß-hCG in saliva, empowering women to carry out early pregnancy detection at any location and moment, simultaneously fostering a more private and shareable testing process.

Which Players Are Part Of The Competitive Landscape Of The Rapid Diagnostic Test Kits Market?

Major companies operating in the rapid diagnostic test kits market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc, bioMerieux SA, QuidelOrtho Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Cepheid Inc, OraSure Technologies Inc, Nova Biomedical Corporation, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, ACON Laboratories Inc, Fluxergy LLC, Lumos Diagnostics Holdings Limited, Abingdon Health plc, Abionic SA

Get The Full Rapid Diagnostic Test Kits Market Report:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostic-test-kits-global-market-report

Which Region Has The Greatest Market Share In The Rapid Diagnostic Test Kits Market?

North America was the largest region in the rapid diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Rapid Diagnostic Test Kits Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostic-test-kits-global-market-report

Browse Through More Reports Similar to the Global Rapid Diagnostic Test Kits Market 2026, By The Business Research Company

Single Dose Radiotherapy Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Image Guided Radiation Therapy Market Report

https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report

Medical Irradiation Market Report

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795